Phenominer Database Results (20 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Average Type Value Units SEM SD Method Method Site Method Duration Post Insult Time Value Method Notes Clinical Measurement Notes Experiment Notes Record ID Study ID
BB.SHR-(Gnal-D18Mit9)/K serum insulin level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood insulin amount both 84 days 25 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay opthalmic venous plexus 0.0 0 ng/ml is unit 70100 324
Crl:WI serum insulin level control condition Korkmaz-Ic?z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. blood insulin amount male 112 days 10 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 102942 2783
GK/MolTac serum insulin level control condition Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 60 days 6 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106917 3071
WKY/NMolTac serum insulin level control condition Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 240 days 9 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106921 3071
DA/K serum insulin level control condition Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. blood insulin amount not specified 196 days-224 days 12 0.0 mg/dl 0.0 0.0 radioimmunoassay 0.0 0 96847 1123
GK/MolTac serum insulin level control condition Korkmaz-Ic?z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. blood insulin amount male 112 days 8 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 102943 2783
BB.SHR-(D6Rat184-D6Rat3)/K serum insulin level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood insulin amount both 84 days 32 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay opthalmic venous plexus 0.0 0 ng/ml is unit 70099 324
GK/Jcl serum insulin level control condition Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. blood insulin amount male 52 days 6 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 103937 2884
GK/MolTac serum insulin level control condition Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 240 days 11 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106918 3071
GK/MolTac serum insulin level control condition Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 420 days 11 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106919 3071
WKY/NMolTac serum insulin level control condition Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 60 days 6 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106920 3071
WKY/NMolTac serum insulin level control condition Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 420 days 9 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106922 3071
WOKW serum insulin level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. blood insulin amount female 196 days-224 days 12 serial mean 0.0 mg/dl radioimmunoassay ophthalmic venous plexus 0.0 0 Roche Cobas Mira Plus (Roche, Switzerland) average of measures taken at 196 days, 210 days and 224 days 67919 251
Jcl:WI serum insulin level control condition Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. blood insulin amount male 52 days 6 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 103936 2884
BB.SHR-(D4Got41-Tacr1)/K serum insulin level control condition Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. blood insulin amount male 224 days 20 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 ng/ml 11938 227
BB.SHR-(D6Rat184-D6Rat3)/K serum insulin level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood insulin amount both 84 days 46 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay opthalmic venous plexus 0.0 0 ng/ml is unit 12981 324
BB.WOKW-(D4Got41-Fabp1)/K serum insulin level control condition Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. blood insulin amount male 224 days 16 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 ng/ml 11942 227
BB/OK serum insulin level control condition Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. blood insulin amount male 224 days 20 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 ng/ml 67939 227
DA/K serum insulin level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. blood insulin amount female 196 days-224 days 12 serial mean 0.0 mg/dl radioimmunoassay ophthalmic venous plexus 0.0 0 Roche Cobas Mira Plus (Roche, Switzerland) average of measures taken at 196 days, 210 days and 224 days 67920 251
WOKW/K serum insulin level control condition Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. blood insulin amount not specified 196 days-224 days 12 0.0 mg/dl 0.0 0.0 radioimmunoassay 0.0 0 96846 1123